Status:
UNKNOWN
Clinical Evaluation and Intervention of Developmental Behavioral Diseases Based on Multicenter Cohort Study(CEIDBDBMCS)
Lead Sponsor:
Chen Li
Collaborating Sponsors:
Southeast University, China
East China Normal University
Conditions:
ADHD
Language Disorders
Eligibility:
All Genders
1-6 years
Phase:
NA
Brief Summary
Diagnosis of Language Disorder and Attention Deficit Hyperactivity Disorder (ADHD) is difficult for several reasons. This study aims to establish a Chinese multi-center cohort for the early diagnosis ...
Detailed Description
1. Procedures. From December 2022 to May 2024, the research team completed the collection and follow-up of 900 cases of language disorder and 1,200 cases of ADHD, and included them in the language dis...
Eligibility Criteria
Inclusion
- 1\. Language disorder
- Inclusion criteria:
- Language disorder(n=900): This study included children between the ages of 1-4 who were evaluated for potential language disorder by two developmental behavioral specialists holding the title of associate professor or higher.
- Control group(n=100): This study included children between the ages of 1-4 who were exclude with language disorder by two developmental behavioral specialists with the title of associate professor or higher.
- Exclusion criteria:
- Children with a history of language development delay or language disorder intervention treatment.
- DQ score below 85.
- (3) Patients with organic diseases of the nervous system, epilepsy, autism spectrum disorder, global developmental delay, and hearing impairment, and/or people caring for patients with mental illness, hearing impairment,language disoeder.
- ADHD
- Inclusion criteria:
- ADHD(n=1200): This study included children between the ages of 3-6 who were evaluated for potential ADHD by two developmental behavioral and/or psychiatrists with the rank of associate professor or higher.
- Control group(n=100):This study included children between the ages of 1-4 who were exclude with ADHD by two developmental behavioral and/or psychiatrists with the rank of associate professor or higher.
- Exclusion criteria:
- Children with ADHD intervention treatment.
- DQ score lower than 85, or IQ score lower than 80.
- Patients with organic diseases of the nervous system, epilepsy, autism spectrum disorder, global developmental delay, mental retardation, atopic dermatitis, asthma, hearing impairment or visual impairment.
Exclusion
Key Trial Info
Start Date :
December 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2025
Estimated Enrollment :
2100 Patients enrolled
Trial Details
Trial ID
NCT06025890
Start Date
December 7 2022
End Date
December 10 2025
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Growth, Development and Mental health of Children and Adolescence Center
Chongqing, Chongqing Municipality, China, 400014